Financier looks to parlay a $5M Alzheimer’s deal into instant $172.5M IPO

Vivek Ramaswamy
Just before Christmas last year, a newly formed Bermuda-based biotech run by former hedge fund partner Vivek Ramaswamy struck a deal to in-license a shelved Alzheimer’s drug from GlaxoSmithKline ($GSK) with plans to put it into Phase III. That late-stage study won’t start until the fourth quarter, but the newborn biotech isn’t waiting around at the starting line. The […]

GSK, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards

[PR Newswire] – RESEARCH TRIANGLE PARK, N.C., May 6, 2014 /PRNewswire/ — GlaxoSmithKline (@GSKUS) and Triangle Community Foundation (@TriComFdn) today issued the call for applications for the GSK IMPACT Awards. This annual awards program will honor up t moreView todays social media effects on GSKView the latest stocks trending across Twitter. Click to view dashboardSee who GlaxoSmithKline is hiring next, […]